Literature DB >> 7526272

Anatomy and physiology of glutamate in the CNS.

J T Greenamyre1, R H Porter.   

Abstract

Glutamate is the predominant excitatory neurotransmitter in the mammalian CNS. The neurotransmitter pool of glutamate is stored in synaptic vesicles and, upon depolarization, is released into the synaptic cleft in a Ca(2+)-dependent fashion. Glutamate is cleared from the synaptic cleft by high-affinity, Na(+)-dependent uptake carriers located in both neurons and glia. Glutamate acts on several distinct families of receptors, each of which has multiple subtypes with distinct pharmacologic and physiologic properties. Under some conditions, glutamate and related compounds act as excitotoxins and might participate in the events leading to neuronal damage and death in a variety of acute and chronic neurologic disorders. The potential for glutamate to become an excitotoxin is highly dependent upon neuronal metabolic status. A great deal of interest in developing selective, well-tolerated glutamate receptor antagonists for the treatment of a variety of neurologic disorders exists.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7526272

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  39 in total

1.  Treatment of late-onset nonketotic hyperglycinaemia: effectiveness of imipramine and benzoate.

Authors:  E J Wiltshire; N K Poplawski; J R Harrison; J M Fletcher
Journal:  J Inherit Metab Dis       Date:  2000-02       Impact factor: 4.982

2.  Hypothalamic digoxin-mediated model for subacute sclerosing panencephalitis.

Authors:  Ravi Kumar Kurup; Parameswara Achutha Kurup
Journal:  J Neurovirol       Date:  2002-08       Impact factor: 2.643

3.  The ability of new non-competitive glutamate receptor blockers to weaken motor disorders in animals.

Authors:  N I Rukoyatkina; L V Gorbunova; V E Gmiro; N Ya Lukomskaya
Journal:  Neurosci Behav Physiol       Date:  2003-03

4.  Anxiolytic-like effects of NMDA/glycine-B receptor ligands are abolished during the elevated plus-maze trial 2 in rats.

Authors:  Leandro J Bertoglio; Antonio P Carobrez
Journal:  Psychopharmacology (Berl)       Date:  2003-09-10       Impact factor: 4.530

Review 5.  Phosphorylation of AMPA receptors: mechanisms and synaptic plasticity.

Authors:  John Q Wang; Anish Arora; Lu Yang; Nikhil K Parelkar; Guochi Zhang; Xianyu Liu; Eun Sang Choe; Limin Mao
Journal:  Mol Neurobiol       Date:  2005-12       Impact factor: 5.590

6.  Memantine decreases hippocampal glutamate levels: a magnetic resonance spectroscopy study.

Authors:  Lidia Glodzik; Kevin G King; Oded Gonen; Songtao Liu; Susan De Santi; Mony J de Leon
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2008-02-07       Impact factor: 5.067

7.  Sigma receptors [σRs]: biology in normal and diseased states.

Authors:  Colin G Rousseaux; Stephanie F Greene
Journal:  J Recept Signal Transduct Res       Date:  2015-06-09       Impact factor: 2.092

Review 8.  Detrimental effects of chronic hypothalamic-pituitary-adrenal axis activation. From obesity to memory deficits.

Authors:  J Raber
Journal:  Mol Neurobiol       Date:  1998-08       Impact factor: 5.590

9.  Abnormal glutamate release in aged BTBR mouse model of autism.

Authors:  Hongen Wei; Caiyun Ding; Guorong Jin; Haizhen Yin; Jianrong Liu; Fengyun Hu
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

10.  Silicon Wafer-Based Platinum Microelectrode Array Biosensor for Near Real-Time Measurement of Glutamate in Vivo.

Authors:  Kate M Wassum; Vanessa M Tolosa; Jianjun Wang; Eric Walker; Harold G Monbouquette; Nigel T Maidment
Journal:  Sensors (Basel)       Date:  2008       Impact factor: 3.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.